Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Papp, Krisztián ^a,b   Végh, Péter ^b   Hóbor, Renáta ^c   Szittner, Zoltán ^a,b   Vokó, Zoltán ^a,d   Podani, János ^a   Czirják, László ^c   Prechl, József ^a,b  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b Diagnosticum Ltd   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Syreon Research Institute   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NUCLEAR PROTEIN ANTIGEN; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEPARATION TECHNIQUE; SEX RATIO; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS; AUTOANTIBODIES; AUTOANTIGENS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN ARRAY ANALYSIS; ROC CURVE;

EID: 84866284113     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044824     Document Type: Article

References (29)

1. Hochberg MC, (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
2. Smeenk R, Brinkman K, van den Brink H, Termaat RM, Berden J, et al. (1990) Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease. Clin Rheumatol 9: 100-110.
3. Liu CC, Ahearn JM, (2009) The search for lupus biomarkers. Best Pract Res Clin Rheumatol 23: 507-523.
4. Sturfelt G, Truedsson L, (2005) Complement and its breakdown products in SLE. Rheumatology (Oxford) 44: 1227-1232.
5. Truedsson L, Bengtsson AA, Sturfelt G, (2007) Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40: 560-566.
6. Valentijn RM, van Overhagen H, Hazevoet HM, Hermans J, Cats A, et al. (1985) The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 28: 904-913.
7. Manzi S, Rairie JE, Carpenter AB, Kelly RH, Jagarlapudi SP, et al. (1996) Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 39: 1178-1188.
8. Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, et al. (2004) Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 50: 3596-3604.
9. Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, et al. (2006) Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum 54: 670-674.
10. Liu CC, Kao AH, Hawkins DM, Manzi S, Sattar A, et al. (2009) Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus. Clin Transl Sci 2: 300-308.
11. Rothfield NF, Stollar BD, (1967) The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest 46: 1785-1794.
12. Valle RR, Eaton RB, Schnneider G, Schur PH, (1985) Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassay. Clin Immunol Immunopathol 34: 345-354.
13. Beaulieu A, Quismorio FP Jr, Friou GJ, Vayuvegula B, Mirick G, (1979) IgG antibodies to double-stranded DNA in systemic lupus erythematosus sera. Independent variation of complement fixing activity and total antibody content. Arthritis Rheum 22: 565-570.
14. Gharavi AE, Elkon KB, Schifferli JA, Hughes GR, (1981) Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus. J Clin Lab Immunol 6: 251-255.
15. Papp K, Szekeres Z, Terenyi N, Isaak A, Erdei A, et al. (2007) On-chip complement activation adds an extra dimension to antigen microarrays. Mol Cell Proteomics 6: 133-140.
16. Papp K, Vegh P, Tchorbanov A, Vassilev T, Erdei A, et al. (2010) Progression of lupus-like disease drives the appearance of complement-activating IgG antibodies in MRL/lpr mice. Rheumatology (Oxford) 49: 2273-2280.
17. Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, et al. (2010) An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 130: 337-343.
18. Li QZ, Zhou J, Wandstrat AE, Carr-Johnson F, Branch V, et al. (2007) Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol 147: 60-70.
19. Li QZ, Xie C, Wu T, Mackay M, Aranow C, et al. (2005) Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115: 3428-3439.
20. Esparza RH, Swaak T, Aarden L, Smeenk R, (1985) Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. J Rheumatol 12: 1109-1117.
21. Ballou SP, Kushner I, (1979) Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus. Clin Exp Immunol 37: 58-67.
22. Teppo AM, Kurki P, Helve T, Wegelius O, (1984) DNA antibodies with and without complement-binding ability. Rheumatol Int 4: 173-176.
23. Edberg JC, Tosic L, Wright EL, Sutherland WM, Taylor RP, (1988) Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. J Immunol 141: 4258-4265.
24. Witte T, (2008) IgM antibodies against dsDNA in SLE. Clinical reviews in allergy & immunology 34: 345-347.
25. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, et al. (2011) Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis and rheumatism 63: 2436-2444.
26. Xu W, Berger SP, Trouw LA, de Boer HC, Schlagwein N, et al. (2008) Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. JOURNAL OF IMMUNOLOGY 180: 7613-7621.
27. Thurman JM, Holers VM, (2006) The central role of the alternative complement pathway in human disease. JOURNAL OF IMMUNOLOGY 176: 1305-1310.
28. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
29. Podani J (2001) SYN-TAX 2000. Computer programs for data analysis in ecology and systematics. User's manual. Budapest: Scientia.